Furthermore, high CAP1 expression was associated with poor tumor characteristics and correlated with expression of genes and biological pathways within growth promoting (such as Abl, RRAGC and mTOR) and cell motility processes (e.g., Arp2/3 complex, ARSB and FN1) in breast cancer. This evidence concerns the gene FN1 and breast carcinoma.